GGrantIndex
Sort

40,608 grants matching prostate cancer

Molecular Targets for Prevention of Prostate Cancer by *

$315,491
Hasan Mukhtar · University Of Wisconsin-Madison · R01 · FY2006 · CA

Project 4: A Targetable Master Regulator of Lethal Prostate Cancer

$315,445
Michael R Freeman · University Of California Los Angeles · P50 · FY2022 · CA

Activated EGF Receptor in Ovarian Cancer

$315,434
University Of New Mexico · R01 · FY2002 · CA

PROSTATIC VASCULOGENIC MIMICRY: A NEW METASTATIC PATHWAY

$315,428
University Of Iowa · R01 · FY2000 · CA

Transcriptional Repression by Polycomb Group Products

$315,428
Jeffrey A Simon · University Of Minnesota · R01 · FY2012 · GM

Comparative Analysis of Surgical Treatment Options for Localized Prostate Cancer

$315,419
James A Eastham · Sloan-Kettering Inst Can Research · RC1 · FY2010 · CA

Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer

$315,400
Gustavo Ayala · University Of Texas Hlth Sci Ctr Houston · R01 · FY2012 · CA

Mechanistic Role of miRNAs and Their Targets in Prostate Cancer Aggressiveness

$315,400
Fazlul H. Sarkar · Wayne State University · R01 · FY2015 · CA

Role of the tumor suppressor KLF6 in prostate cancer

$315,400
John A Martignetti · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · CA

Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer

$315,400
Izabela Podgorski · Wayne State University · R01 · FY2015 · CA

Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer

$315,400
Izabela Podgorski · Wayne State University · R01 · FY2017 · CA

Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer

$315,400
Izabela Podgorski · Wayne State University · R01 · FY2016 · CA

Role of the tumor suppressor KLF6 in prostate cancer

$315,400
John A Martignetti · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA

PDGF D AND PROSTATE CANCER BONE METASTASIS

$315,400
Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2010 · CA

Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer

$315,400
Izabela Podgorski · Wayne State University · R01 · FY2018 · CA

Efficacy and Mechanism of Novel Androgen Receptor Inhibitors

$315,400
Marc I Diamond · Washington University · R01 · FY2010 · CA

Role of the tumor suppressor KLF6 in prostate cancer

$315,400
John A Martignetti · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · CA

Mechanistic Role of miRNAs and Their Targets in Prostate Cancer Aggressiveness

$315,400
Fazlul H. Sarkar · Wayne State University · R01 · FY2012 · CA

Integrative Metabolomics of Prostate Cancer Progression

$315,400
Arun Sreekumar · University Of Michigan At Ann Arbor · R01 · FY2008 · CA

Pax2 interacting proteins in Development and Disease

$315,394
Gregory R Dressler · University Of Michigan At Ann Arbor · R01 · FY2010 · DK

Genomics and Predictive Modeling of Prostate Cancer Heath Disparity

$315,393
Harry Ostrer · Albert Einstein College Of Medicine, Inc · U01 · FY2015 · CA

Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.

$315,367
Arnold I. Caplan · Case Western Reserve University · R01 · FY2012 · CA

Automatic Pelvic Organ Delineation in Prostate Cancer Treatment

$315,338
Jun Lian · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA

Project 1- Role of fat in metastatic engraftment and expansion in the liver

$315,322
Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2022 · CA

Anti-CXCL13 mAb to mitigate prostate cancer health disparities

$315,320
Shailesh Singh · Jyant, Inc. · R41 · FY2015 · MD